|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Kuopio University Hospital |
| Information provided by: | Kuopio University Hospital |
| ClinicalTrials.gov Identifier: | NCT00442494 |
Purpose
Atrial fibrillation is the most common arrhythmia to occur after cardiac surgery. Inflammatory response may be one etiological factor.
We hypothesized that intravenous corticosteroid administration after cardiac surgery prevents AF after cardiac surgery.
| Condition | Intervention | Phase |
|
Atrial Fibrillation |
Drug: intravenous hydrocortisone |
Phase III |
| Genetics Home Reference related topics: | Brugada syndrome familial atrial fibrillation short QT syndrome |
| MedlinePlus related topics: | Surgery |
| Study Type: | Interventional |
| Study Design: | Randomized, Double-Blind, Placebo Control, Parallel Assignment, Efficacy Study |
| Official Title: | Feasibility of Corticosteroid in the Prevention of Atrial Fibrillation After Cardiac Surgery: A Prospective, Double-Blind Randomized Multicenter Trial |
Eligibility
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
Contacts and Locations
More Information
| Study ID Numbers: | KUH5204515 |
| First Received: | March 1, 2007 |
| Last Updated: | January 11, 2008 |
| ClinicalTrials.gov Identifier: | NCT00442494 |
| Health Authority: | Finland: National Agency for Medicines |
|
|
|
|